Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$247.84 - $340.0 $4.55 Million - $6.24 Million
18,346 Added 15.11%
139,768 $47 Million
Q4 2023

Feb 14, 2024

SELL
$222.83 - $285.76 $11.7 Million - $15 Million
-52,432 Reduced 30.16%
121,422 $34.4 Million
Q3 2023

Nov 14, 2023

SELL
$236.44 - $265.62 $40.1 Million - $45.1 Million
-169,783 Reduced 49.41%
173,854 $42.8 Million
Q2 2023

Aug 14, 2023

BUY
$183.12 - $250.2 $61.9 Million - $84.6 Million
337,951 Added 5943.56%
343,637 $86 Million
Q1 2023

May 15, 2023

SELL
$193.59 - $245.33 $30.2 Million - $38.2 Million
-155,855 Reduced 96.48%
5,686 $1.21 Million
Q4 2022

Feb 14, 2023

BUY
$173.9 - $224.8 $28.1 Million - $36.3 Million
161,541 New
161,541 $31.4 Million
Q2 2022

Aug 15, 2022

SELL
$197.3 - $261.32 $78.2 Million - $104 Million
-396,331 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$216.09 - $296.03 $48.2 Million - $66.1 Million
-223,199 Reduced 36.03%
396,331 $96.4 Million
Q4 2021

Feb 14, 2022

BUY
$258.11 - $309.7 $159 Million - $191 Million
617,927 Added 38548.16%
619,530 $192 Million
Q3 2021

Nov 15, 2021

SELL
$208.53 - $283.04 $11.6 Million - $15.8 Million
-55,822 Reduced 97.21%
1,603 $420,000
Q2 2021

Aug 13, 2021

BUY
$194.07 - $232.2 $3.74 Million - $4.48 Million
19,279 Added 50.54%
57,425 $11.9 Million
Q1 2021

May 17, 2021

BUY
$171.87 - $220.96 $6.56 Million - $8.43 Million
38,146 New
38,146 $7.49 Million
Q4 2020

Feb 16, 2021

SELL
$180.3 - $214.08 $284,152 - $337,390
-1,576 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$166.91 - $196.1 $1.74 Million - $2.05 Million
-10,452 Reduced 86.9%
1,576 $301,000
Q2 2020

Aug 13, 2020

SELL
$129.79 - $170.94 $1.88 Million - $2.48 Million
-14,511 Reduced 54.68%
12,028 $2.03 Million
Q1 2020

May 15, 2020

BUY
$115.95 - $177.22 $2.85 Million - $4.36 Million
24,613 Added 1277.93%
26,539 $3.61 Million
Q4 2019

Feb 14, 2020

SELL
$139.48 - $172.23 $778,437 - $961,215
-5,581 Reduced 74.34%
1,926 $332,000
Q3 2019

Nov 14, 2019

SELL
$146.89 - $161.41 $9.81 Million - $10.8 Million
-66,797 Reduced 89.9%
7,507 $1.11 Million
Q2 2019

Aug 14, 2019

BUY
$129.99 - $153.97 $8.22 Million - $9.74 Million
63,233 Added 571.16%
74,304 $11.4 Million
Q1 2019

May 14, 2019

SELL
$121.3 - $146.95 $4.75 Million - $5.75 Million
-39,147 Reduced 77.95%
11,071 $1.51 Million
Q4 2018

Feb 14, 2019

BUY
$119.37 - $153.29 $3.12 Million - $4.01 Million
26,151 Added 108.66%
50,218 $6.49 Million
Q3 2018

Nov 14, 2018

BUY
$131.3 - $153.75 $3.16 Million - $3.7 Million
24,067 New
24,067 $3.7 Million

Others Institutions Holding ICLR

About ICON PLC


  • Ticker ICLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 81,526,600
  • Market Cap $16.2B
  • Description
  • ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...
More about ICLR
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.